Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma

NCT00441818 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
59
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tanox